PL2714705T3 - Sole magnezu ośmiosiarczanu sacharozy, sposób ich wytwarzania i ich zastosowania farmaceutyczne i kosmetyczne - Google Patents

Sole magnezu ośmiosiarczanu sacharozy, sposób ich wytwarzania i ich zastosowania farmaceutyczne i kosmetyczne

Info

Publication number
PL2714705T3
PL2714705T3 PL12724633T PL12724633T PL2714705T3 PL 2714705 T3 PL2714705 T3 PL 2714705T3 PL 12724633 T PL12724633 T PL 12724633T PL 12724633 T PL12724633 T PL 12724633T PL 2714705 T3 PL2714705 T3 PL 2714705T3
Authority
PL
Poland
Prior art keywords
octasulfates
sucrose
pharmaceutical
magnesium
preparation
Prior art date
Application number
PL12724633T
Other languages
English (en)
Inventor
Séverine Jeulin
Hélène Hernandez-Pigeon
Luc Aguilar
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of PL2714705T3 publication Critical patent/PL2714705T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
PL12724633T 2011-05-31 2012-05-31 Sole magnezu ośmiosiarczanu sacharozy, sposób ich wytwarzania i ich zastosowania farmaceutyczne i kosmetyczne PL2714705T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1154752A FR2975993B1 (fr) 2011-05-31 2011-05-31 Sucroses octasulfates de magnesium, leur preparation et leurs applications pharmaceutiques et cosmetiques
EP12724633.8A EP2714705B1 (fr) 2011-05-31 2012-05-31 Sucroses octasulfates de magnesium, leur preparation et leurs applications pharmaceutiques et cosmetiques
PCT/EP2012/060211 WO2012163997A1 (fr) 2011-05-31 2012-05-31 Sucroses octasulfates de magnesium, leur preparation et leurs applications pharmaceutiques et cosmetiques

Publications (1)

Publication Number Publication Date
PL2714705T3 true PL2714705T3 (pl) 2015-09-30

Family

ID=46197271

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12724633T PL2714705T3 (pl) 2011-05-31 2012-05-31 Sole magnezu ośmiosiarczanu sacharozy, sposób ich wytwarzania i ich zastosowania farmaceutyczne i kosmetyczne

Country Status (8)

Country Link
US (1) US9562065B2 (pl)
EP (1) EP2714705B1 (pl)
JP (1) JP5998211B2 (pl)
ES (1) ES2541476T3 (pl)
FR (1) FR2975993B1 (pl)
PL (1) PL2714705T3 (pl)
PT (1) PT2714705E (pl)
WO (1) WO2012163997A1 (pl)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1390007A (fr) 1964-04-13 1965-02-19 Plage permettant d'intégrer sur un disque un enregistrement publicitaire ou autre
US4098995A (en) * 1976-07-12 1978-07-04 American Cyanamid Company Polygalactosido-sucrose poly(h-)sulfate salts
AU607690B2 (en) 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
DK191889D0 (da) * 1989-04-20 1989-04-20 Bukh Meditec Kosmetisk middel
US5618798A (en) * 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
FR2646604B1 (fr) 1989-05-03 1994-02-04 Fabre Medicament Pierre Composition pour usage externe a base de sucralfate et son procede de preparation
DK86492D0 (da) 1992-06-30 1992-06-30 Bukh Meditec Laegemiddel
US7795239B2 (en) * 1992-07-27 2010-09-14 Mueller Medical International LLC Saccharide compositions and method of use
WO2006017752A2 (en) * 2004-08-05 2006-02-16 Ivax Corporation Sulfated oligosaccharides
FR2916355B1 (fr) 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation

Also Published As

Publication number Publication date
JP5998211B2 (ja) 2016-09-28
US9562065B2 (en) 2017-02-07
PT2714705E (pt) 2015-08-05
WO2012163997A1 (fr) 2012-12-06
US20140121180A1 (en) 2014-05-01
EP2714705A1 (fr) 2014-04-09
ES2541476T3 (es) 2015-07-20
FR2975993B1 (fr) 2013-06-28
EP2714705B1 (fr) 2015-04-22
FR2975993A1 (fr) 2012-12-07
JP2014515388A (ja) 2014-06-30

Similar Documents

Publication Publication Date Title
ZA201503188B (en) Products including capsules, uses and preparation thereof
IL238064B (en) A formulation containing smallpox virus, a method for preparing a freeze-dried formulation and their uses
HUE038664T2 (hu) Hialuronsav C6-C18-acilezett származéka, eljárás annak elõállítására, erre épülõ nanomicelláris kompozíció, eljárás annak elõállítására és eljárás stabilizált nanomicelláris kompozíció elõállítására, valamint annak alkalmazása
IL252566B (en) Pharmacy preparations and methods
PL2882779T3 (pl) Pochodna kwasu hialuronowego, sposób jej wytwarzania, sposób jej modyfikacji i jej zastosowanie
EP2585606A4 (en) SUGAR MIXTURES, METHODS OF PRODUCTION AND USE THEREOF
EP2763998A4 (en) TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF
PL2930169T3 (pl) Krystaliczna postać chidamidu, sposób jej wytwarzania i zastosowanie
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
IL233238A (en) Sulphonylaminopyrrolidinone derivatives, their preparation and therapeutic use
IL239054A0 (en) History of azaquinazoline carboxamide, their preparation and pharmaceutical preparations containing them
IL231505B (en) Pharmaceutical preparation and method for its production
ZA201306905B (en) Novel octahydrothienoquinonline derivative,pharmaceutical composition comprising derivative, and use of these
ZA201305277B (en) Phenyl-isoxazol derivatives and preparation process thereof
IL228705A (en) Derivatives of Reliable Phenoxy-Ethyl, Pharmaceutical Preparations Containing and Using Them
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
EP2816993A4 (en) SKIN CARE PRODUCT AND PROCESS FOR PREPARING THE SAME
EP2786989A4 (en) 2-ALKYL OR ARYL-SUBSTITUTED TANSHINONE DERIVATIVES, METHOD OF MANUFACTURING THEREOF AND THE APPLICATION THEREOF
EP2925436A4 (en) METAL PHOSPHATE MOLECULAR SIEBE, METHOD FOR THE PREPARATION AND USE
SG11201405376TA (en) CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β, 5, 6β-TRIOL AND PREPARATION METHODS THEREOF
GB201208315D0 (en) Pharmaceutical methods and compositions
HRP20180781T1 (hr) Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme
PT2714705E (pt) Sacarose-octassulfatos de magnésio, o seu método de preparação e suas utilizações farmacêuticas e cosméticas
IL234614B (en) Pharmaceutical composition and preparation method thereof
GB201112578D0 (en) Pharmaceutical preparation and use